SlideShare a Scribd company logo
1 of 16
1
The 2nd EORTC Cancer Clinical Research Methodology Course
for Patient Advocates – Brussels – March 4-5, 2016
The Role of Patients
& their Challenges in Clinical Trials
How to communicate “trial information & results”
to patients
Kathi Apostolidis
Vice President – European Cancer Patient Coalition
President – Hellenic Cancer Federation
2
ECPC: "Nothing about us, without us"
• Members: 383 cancer patient organizations in 44
countries
• All cancers – common and rare
• Run and governed by patients
• Promoting timely access to prevention, screening,
early diagnosis, treatment & care for all cancer patients
• Reducing disparity and inequity across the EU
• Encouraging the advance of cancer research &
innovation & patient involvement in research
• Increasing cancer patients' influence over European
health and research policy
3
European Cancer Patient Coalition’s Activities
4
European Commission
• Joint Action on Cancer Control – CanCon
• Joint Action on Rare Cancers
• European Commission’s Expert Group on Cancer Control
• European Commission Initiative on Breast Cancer-Quality
Assurance Scheme Development Group (ECIBC/QASDG)
• Working Group on mHealth guidelines assessment
European Medicines Agency
• Patients’ and Consumers’ Working Party
ECPC: cancer patients’recognised voice
5
What are clinical trials
Myths about clinical trials
What patients want
The role of patients in clinical trials
How to communicate trial
information
How to communicate trial results
6
7
Questions clinical trials can answer
 Is a new treatment or combination safe? How
much?
 Is a new treatment effective?
 Is a new treatment better than or same to the
currently available treatments?
 Will all patients benefit? Or some will benefit
less?
 Are there biomarkers or other testing to
determine which patients will benefit most?
8
Clinical Trial Design
Umbrella Trial -
lhttp://www.roche.com/media/store/roche_stories/as
co-2015-overview/asco-2015-story-2.htmla
www.institute-curie.org
9
Myths about Clinical Trials
1st Myth: Clinical Trial as Last Resort
2nd Myth: Patients as Guinea pigs,
especially in Phase I
3rd Myth: Placebo
4th Myth: No stopping or Going Back
10
Why patients enter Phase III trials
To do social good
Trust in his/her doctor
Favorable impression of the clinical research
associate
Lack of pressure to enter the trial
Sufficient information for decision making
Sufficient time to make decision
Favor for clinical trials
Expectation to do well
Support from family and friends
James R. Wright et al. 2004
11
The Role of Patients in Clinical Trials
From research subject…
…to research partners…
12
13
14
The Advanced Symptom Management System
(ASyMS)• Mobile phone-based
• Utilises an electronic
Patient-Reported Outcomes
(ePRO) measure, so ePRO
system
Sunday, 06 14
Patient completes ePRO
symptom questionnaire on
mobile phone on a daily basis
and whenever he/she feels
unwell
Data transferred to server and
subject to clinical risk algorithm
Alerts transmitted to
clinician’s handset
Evidence-
based self-
manageme
nt advice
Amber alert
(mild
symptoms)
Red alert
(severe or life-
threatening
symptoms)
E-Library
Symptom
graphs
Clinician logs onto website
to review alert
and contacts patient
Automated
message
prompts patient
to check self-
care advice
! !!
Real-time
Real-time Real-time
Real-time
15
Trial results communication to patients
• Clinical trials results should be made available to
participants
• Providing results is the ethical standard
• Most patients want to know the results
• Women felt it should be their doctor who shares
the results
• Plan to share the results should be included in
the Informed Consent
• Guidelines needed for the optimum time to share
results
• Results should be shared before public disclosure
16
Thank for your attention
Nothing about us without us!
email : kathi.apostolidis@ecpc.org
@cancereu
European Cancer Patient
Coalition
ECPCtv

More Related Content

What's hot

The Pursuit of Precision Healthcare-Patient needs in personalized healthcare
The Pursuit of Precision Healthcare-Patient needs in personalized healthcareThe Pursuit of Precision Healthcare-Patient needs in personalized healthcare
The Pursuit of Precision Healthcare-Patient needs in personalized healthcareKathi Apostolidis
 
Jillian Hastings Ward: Genomics England Towards 5 Million Genomes in the UK
Jillian Hastings Ward: Genomics England Towards 5 Million Genomes in the UKJillian Hastings Ward: Genomics England Towards 5 Million Genomes in the UK
Jillian Hastings Ward: Genomics England Towards 5 Million Genomes in the UKJoe Ball
 
The Virtual Consulting Room (Berlingieri)
The Virtual Consulting Room (Berlingieri)The Virtual Consulting Room (Berlingieri)
The Virtual Consulting Room (Berlingieri)Pasquale Berlingieri
 
The benefits of patient involvement in research and development (RE:ACT Congr...
The benefits of patient involvement in research and development (RE:ACT Congr...The benefits of patient involvement in research and development (RE:ACT Congr...
The benefits of patient involvement in research and development (RE:ACT Congr...jangeissler
 
Bariatric Surgery Med-e-tel 2013
Bariatric Surgery Med-e-tel 2013Bariatric Surgery Med-e-tel 2013
Bariatric Surgery Med-e-tel 2013i2healthsantpau
 
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the InternetJan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internetpatvocates
 
Workshop 3 - "Feedback from the 15 National Conferences on Registries"
Workshop 3 - "Feedback from the 15 National Conferences on Registries" Workshop 3 - "Feedback from the 15 National Conferences on Registries"
Workshop 3 - "Feedback from the 15 National Conferences on Registries" EURORDIS - Rare Diseases Europe
 
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...EUPATI
 
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI
 
ECPC involvement in research
ECPC involvement in researchECPC involvement in research
ECPC involvement in researchKathi Apostolidis
 
Rare disease day - feb 29th 2016 - Eilish Hardiman
Rare disease day - feb 29th 2016 - Eilish HardimanRare disease day - feb 29th 2016 - Eilish Hardiman
Rare disease day - feb 29th 2016 - Eilish Hardimanipposi
 
EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...
EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...
EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...EUPATI
 
Workshop 4 - "Presentation of the RD Platform fact finding study on the trend...
Workshop 4 - "Presentation of the RD Platform fact finding study on the trend...Workshop 4 - "Presentation of the RD Platform fact finding study on the trend...
Workshop 4 - "Presentation of the RD Platform fact finding study on the trend...EURORDIS - Rare Diseases Europe
 
Patient handling equipment market
Patient handling equipment marketPatient handling equipment market
Patient handling equipment marketAkshay Shinde
 
Workshop 2 - "Presentation of the concept, definitions and terminology"
Workshop 2  - "Presentation of the concept, definitions and terminology" Workshop 2  - "Presentation of the concept, definitions and terminology"
Workshop 2 - "Presentation of the concept, definitions and terminology" EURORDIS - Rare Diseases Europe
 
EWMA 2013 - Ep547 - European wound-registry (EWR) -characteristics and method...
EWMA 2013 - Ep547 - European wound-registry (EWR) -characteristics and method...EWMA 2013 - Ep547 - European wound-registry (EWR) -characteristics and method...
EWMA 2013 - Ep547 - European wound-registry (EWR) -characteristics and method...EWMAConference
 
Stratified Medicines Innovation Platform, Graham Bell
Stratified Medicines Innovation Platform, Graham BellStratified Medicines Innovation Platform, Graham Bell
Stratified Medicines Innovation Platform, Graham BellBioDundee
 

What's hot (19)

The Pursuit of Precision Healthcare-Patient needs in personalized healthcare
The Pursuit of Precision Healthcare-Patient needs in personalized healthcareThe Pursuit of Precision Healthcare-Patient needs in personalized healthcare
The Pursuit of Precision Healthcare-Patient needs in personalized healthcare
 
Jillian Hastings Ward: Genomics England Towards 5 Million Genomes in the UK
Jillian Hastings Ward: Genomics England Towards 5 Million Genomes in the UKJillian Hastings Ward: Genomics England Towards 5 Million Genomes in the UK
Jillian Hastings Ward: Genomics England Towards 5 Million Genomes in the UK
 
The Virtual Consulting Room (Berlingieri)
The Virtual Consulting Room (Berlingieri)The Virtual Consulting Room (Berlingieri)
The Virtual Consulting Room (Berlingieri)
 
The benefits of patient involvement in research and development (RE:ACT Congr...
The benefits of patient involvement in research and development (RE:ACT Congr...The benefits of patient involvement in research and development (RE:ACT Congr...
The benefits of patient involvement in research and development (RE:ACT Congr...
 
Bariatric Surgery Med-e-tel 2013
Bariatric Surgery Med-e-tel 2013Bariatric Surgery Med-e-tel 2013
Bariatric Surgery Med-e-tel 2013
 
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the InternetJan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
 
Workshop 3 - "Feedback from the 15 National Conferences on Registries"
Workshop 3 - "Feedback from the 15 National Conferences on Registries" Workshop 3 - "Feedback from the 15 National Conferences on Registries"
Workshop 3 - "Feedback from the 15 National Conferences on Registries"
 
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
 
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
 
ECPC involvement in research
ECPC involvement in researchECPC involvement in research
ECPC involvement in research
 
Rare disease day - feb 29th 2016 - Eilish Hardiman
Rare disease day - feb 29th 2016 - Eilish HardimanRare disease day - feb 29th 2016 - Eilish Hardiman
Rare disease day - feb 29th 2016 - Eilish Hardiman
 
EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...
EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...
EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...
 
Workshop 4 - "Presentation of the RD Platform fact finding study on the trend...
Workshop 4 - "Presentation of the RD Platform fact finding study on the trend...Workshop 4 - "Presentation of the RD Platform fact finding study on the trend...
Workshop 4 - "Presentation of the RD Platform fact finding study on the trend...
 
Xplore health Lesson Plan
Xplore health Lesson PlanXplore health Lesson Plan
Xplore health Lesson Plan
 
Session 3.1 Libutti
Session 3.1 LibuttiSession 3.1 Libutti
Session 3.1 Libutti
 
Patient handling equipment market
Patient handling equipment marketPatient handling equipment market
Patient handling equipment market
 
Workshop 2 - "Presentation of the concept, definitions and terminology"
Workshop 2  - "Presentation of the concept, definitions and terminology" Workshop 2  - "Presentation of the concept, definitions and terminology"
Workshop 2 - "Presentation of the concept, definitions and terminology"
 
EWMA 2013 - Ep547 - European wound-registry (EWR) -characteristics and method...
EWMA 2013 - Ep547 - European wound-registry (EWR) -characteristics and method...EWMA 2013 - Ep547 - European wound-registry (EWR) -characteristics and method...
EWMA 2013 - Ep547 - European wound-registry (EWR) -characteristics and method...
 
Stratified Medicines Innovation Platform, Graham Bell
Stratified Medicines Innovation Platform, Graham BellStratified Medicines Innovation Platform, Graham Bell
Stratified Medicines Innovation Platform, Graham Bell
 

Viewers also liked

mhealth in cancer supportive care - how eSMART can improve quality of life
mhealth in cancer supportive care - how eSMART can improve quality of lifemhealth in cancer supportive care - how eSMART can improve quality of life
mhealth in cancer supportive care - how eSMART can improve quality of lifeKathi Apostolidis
 
Fraud & misconduct by Mukesh Jaiswal
Fraud & misconduct by Mukesh JaiswalFraud & misconduct by Mukesh Jaiswal
Fraud & misconduct by Mukesh JaiswalMukesh Jaiswal
 
ClinActis: Logistics of Asian Based Clinical Trials
ClinActis: Logistics of Asian Based Clinical TrialsClinActis: Logistics of Asian Based Clinical Trials
ClinActis: Logistics of Asian Based Clinical TrialsClinActis Pte Ltd
 
Clinical Trials in India
Clinical Trials in IndiaClinical Trials in India
Clinical Trials in Indiavaatsalya
 
History of clinical trials
History of clinical trialsHistory of clinical trials
History of clinical trialsUrmila Aswar
 
Clinical Trials Registry
Clinical Trials RegistryClinical Trials Registry
Clinical Trials Registrybiinoida
 
Key Concepts of Clinical Research & Clinical Trial
Key Concepts of Clinical Research & Clinical Trial Key Concepts of Clinical Research & Clinical Trial
Key Concepts of Clinical Research & Clinical Trial SWAROOP KUMAR K
 
Clinical Trials Introduction
Clinical Trials IntroductionClinical Trials Introduction
Clinical Trials Introductionbiinoida
 
Clinical trials flow process
Clinical trials flow processClinical trials flow process
Clinical trials flow processTamer Hifnawy
 
Imaging biomarkers in Clinical trials
Imaging biomarkers in Clinical trialsImaging biomarkers in Clinical trials
Imaging biomarkers in Clinical trialsAnke Maertens
 
Monitoring and auditing in clinical trials
Monitoring and auditing in clinical trialsMonitoring and auditing in clinical trials
Monitoring and auditing in clinical trialsJyotsna Kapoor
 
Clinical Trials Strategy: The Clinical Development Plan
Clinical Trials Strategy: The Clinical Development PlanClinical Trials Strategy: The Clinical Development Plan
Clinical Trials Strategy: The Clinical Development PlanMaRS Discovery District
 

Viewers also liked (18)

Scope valtierra 2016
Scope valtierra 2016Scope valtierra 2016
Scope valtierra 2016
 
mhealth in cancer supportive care - how eSMART can improve quality of life
mhealth in cancer supportive care - how eSMART can improve quality of lifemhealth in cancer supportive care - how eSMART can improve quality of life
mhealth in cancer supportive care - how eSMART can improve quality of life
 
Drug accountability
Drug accountabilityDrug accountability
Drug accountability
 
Fraud & misconduct by Mukesh Jaiswal
Fraud & misconduct by Mukesh JaiswalFraud & misconduct by Mukesh Jaiswal
Fraud & misconduct by Mukesh Jaiswal
 
ClinActis: Logistics of Asian Based Clinical Trials
ClinActis: Logistics of Asian Based Clinical TrialsClinActis: Logistics of Asian Based Clinical Trials
ClinActis: Logistics of Asian Based Clinical Trials
 
Clinical Trials in India
Clinical Trials in IndiaClinical Trials in India
Clinical Trials in India
 
History of clinical trials
History of clinical trialsHistory of clinical trials
History of clinical trials
 
Clinical Trials Registry
Clinical Trials RegistryClinical Trials Registry
Clinical Trials Registry
 
Designs of clinical trials
Designs of clinical trialsDesigns of clinical trials
Designs of clinical trials
 
Key Concepts of Clinical Research & Clinical Trial
Key Concepts of Clinical Research & Clinical Trial Key Concepts of Clinical Research & Clinical Trial
Key Concepts of Clinical Research & Clinical Trial
 
Clinical Trials Introduction
Clinical Trials IntroductionClinical Trials Introduction
Clinical Trials Introduction
 
Clinical trials flow process
Clinical trials flow processClinical trials flow process
Clinical trials flow process
 
Clinical Trial Phases
Clinical Trial PhasesClinical Trial Phases
Clinical Trial Phases
 
Imaging biomarkers in Clinical trials
Imaging biomarkers in Clinical trialsImaging biomarkers in Clinical trials
Imaging biomarkers in Clinical trials
 
Monitoring and auditing in clinical trials
Monitoring and auditing in clinical trialsMonitoring and auditing in clinical trials
Monitoring and auditing in clinical trials
 
Clinical Trials Strategy: The Clinical Development Plan
Clinical Trials Strategy: The Clinical Development PlanClinical Trials Strategy: The Clinical Development Plan
Clinical Trials Strategy: The Clinical Development Plan
 
Clinical trial design
Clinical trial designClinical trial design
Clinical trial design
 
Clinical Trials - An Introduction
Clinical Trials - An IntroductionClinical Trials - An Introduction
Clinical Trials - An Introduction
 

Similar to The Role of Patients & their Challenges in Clinical Trials

Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...
Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...
Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...patvocates
 
mHealth Israel_Adam Dicker_SVP, Chair, Radiation Oncology_Jefferson Universit...
mHealth Israel_Adam Dicker_SVP, Chair, Radiation Oncology_Jefferson Universit...mHealth Israel_Adam Dicker_SVP, Chair, Radiation Oncology_Jefferson Universit...
mHealth Israel_Adam Dicker_SVP, Chair, Radiation Oncology_Jefferson Universit...Levi Shapiro
 
CURE OM Patient Registry Update - 2019 CURE OM Symposium
CURE OM Patient Registry Update - 2019 CURE OM SymposiumCURE OM Patient Registry Update - 2019 CURE OM Symposium
CURE OM Patient Registry Update - 2019 CURE OM SymposiumMelanoma Research Foundation
 
Access to treatment, care and clinical trials by patients with rare cancers...
Access to treatment, care and clinical trials by patients with rare cancers...Access to treatment, care and clinical trials by patients with rare cancers...
Access to treatment, care and clinical trials by patients with rare cancers...patvocates
 
Earli19 presentation 13 aug19_charitonos_littlejohn
Earli19 presentation 13 aug19_charitonos_littlejohnEarli19 presentation 13 aug19_charitonos_littlejohn
Earli19 presentation 13 aug19_charitonos_littlejohnAllison Littlejohn
 
2014 Berlin_ Operational Excellence in Clinical Trails
2014 Berlin_ Operational Excellence in Clinical Trails2014 Berlin_ Operational Excellence in Clinical Trails
2014 Berlin_ Operational Excellence in Clinical TrailsKaren Radley
 
What's new in the uk nsc
What's new in the uk nscWhat's new in the uk nsc
What's new in the uk nscPHEScreening
 
SHARE Presentation: Maximizing Treatment Options -- What to Know When Conside...
SHARE Presentation: Maximizing Treatment Options -- What to Know When Conside...SHARE Presentation: Maximizing Treatment Options -- What to Know When Conside...
SHARE Presentation: Maximizing Treatment Options -- What to Know When Conside...bkling
 
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldChanges in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldjangeissler
 
SMi Group's 12th annual Paediatric Clinical Trials 2018
SMi Group's 12th annual Paediatric Clinical Trials 2018SMi Group's 12th annual Paediatric Clinical Trials 2018
SMi Group's 12th annual Paediatric Clinical Trials 2018Dale Butler
 
Global Academic Program of MD Anderson Cancer Center
Global Academic Program of MD Anderson Cancer CenterGlobal Academic Program of MD Anderson Cancer Center
Global Academic Program of MD Anderson Cancer Centerspa718
 
Patient engagement in clinical trials
Patient engagement in clinical trials Patient engagement in clinical trials
Patient engagement in clinical trials Martin Kelly
 
Centro de Investigacion de cancer en Guatemala
Centro de Investigacion de cancer en Guatemala Centro de Investigacion de cancer en Guatemala
Centro de Investigacion de cancer en Guatemala Hugo Raul Castro Salguero
 
Dr Colin Gaynor - Project managers as truth seekers - it's in our DNA
Dr Colin Gaynor - Project managers as truth seekers - it's in our DNADr Colin Gaynor - Project managers as truth seekers - it's in our DNA
Dr Colin Gaynor - Project managers as truth seekers - it's in our DNAAssociation for Project Management
 

Similar to The Role of Patients & their Challenges in Clinical Trials (20)

Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...
Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...
Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...
 
mHealth Israel_Adam Dicker_SVP, Chair, Radiation Oncology_Jefferson Universit...
mHealth Israel_Adam Dicker_SVP, Chair, Radiation Oncology_Jefferson Universit...mHealth Israel_Adam Dicker_SVP, Chair, Radiation Oncology_Jefferson Universit...
mHealth Israel_Adam Dicker_SVP, Chair, Radiation Oncology_Jefferson Universit...
 
CURE OM Patient Registry Update - 2019 CURE OM Symposium
CURE OM Patient Registry Update - 2019 CURE OM SymposiumCURE OM Patient Registry Update - 2019 CURE OM Symposium
CURE OM Patient Registry Update - 2019 CURE OM Symposium
 
Pranesh Chakraborty (CHEO): panCanadian Newborn Screening Guidelines
Pranesh Chakraborty (CHEO): panCanadian Newborn Screening GuidelinesPranesh Chakraborty (CHEO): panCanadian Newborn Screening Guidelines
Pranesh Chakraborty (CHEO): panCanadian Newborn Screening Guidelines
 
ICH GCP
ICH GCPICH GCP
ICH GCP
 
P 113 geriatric
P 113 geriatricP 113 geriatric
P 113 geriatric
 
Access to treatment, care and clinical trials by patients with rare cancers...
Access to treatment, care and clinical trials by patients with rare cancers...Access to treatment, care and clinical trials by patients with rare cancers...
Access to treatment, care and clinical trials by patients with rare cancers...
 
Earli19 presentation 13 aug19_charitonos_littlejohn
Earli19 presentation 13 aug19_charitonos_littlejohnEarli19 presentation 13 aug19_charitonos_littlejohn
Earli19 presentation 13 aug19_charitonos_littlejohn
 
Earli19
Earli19Earli19
Earli19
 
2014 Berlin_ Operational Excellence in Clinical Trails
2014 Berlin_ Operational Excellence in Clinical Trails2014 Berlin_ Operational Excellence in Clinical Trails
2014 Berlin_ Operational Excellence in Clinical Trails
 
What's new in the uk nsc
What's new in the uk nscWhat's new in the uk nsc
What's new in the uk nsc
 
SHARE Presentation: Maximizing Treatment Options -- What to Know When Conside...
SHARE Presentation: Maximizing Treatment Options -- What to Know When Conside...SHARE Presentation: Maximizing Treatment Options -- What to Know When Conside...
SHARE Presentation: Maximizing Treatment Options -- What to Know When Conside...
 
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldChanges in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical world
 
Respect patient needs
Respect patient needsRespect patient needs
Respect patient needs
 
SMi Group's 12th annual Paediatric Clinical Trials 2018
SMi Group's 12th annual Paediatric Clinical Trials 2018SMi Group's 12th annual Paediatric Clinical Trials 2018
SMi Group's 12th annual Paediatric Clinical Trials 2018
 
Global Academic Program of MD Anderson Cancer Center
Global Academic Program of MD Anderson Cancer CenterGlobal Academic Program of MD Anderson Cancer Center
Global Academic Program of MD Anderson Cancer Center
 
CURE OM Patient Registry Update
CURE OM Patient Registry UpdateCURE OM Patient Registry Update
CURE OM Patient Registry Update
 
Patient engagement in clinical trials
Patient engagement in clinical trials Patient engagement in clinical trials
Patient engagement in clinical trials
 
Centro de Investigacion de cancer en Guatemala
Centro de Investigacion de cancer en Guatemala Centro de Investigacion de cancer en Guatemala
Centro de Investigacion de cancer en Guatemala
 
Dr Colin Gaynor - Project managers as truth seekers - it's in our DNA
Dr Colin Gaynor - Project managers as truth seekers - it's in our DNADr Colin Gaynor - Project managers as truth seekers - it's in our DNA
Dr Colin Gaynor - Project managers as truth seekers - it's in our DNA
 

More from Kathi Apostolidis

Why Humanities & Art are important in medical education
Why Humanities & Art are important in medical educationWhy Humanities & Art are important in medical education
Why Humanities & Art are important in medical educationKathi Apostolidis
 
ESMO-ECPC Cancer Survivorship Guide
ESMO-ECPC Cancer Survivorship GuideESMO-ECPC Cancer Survivorship Guide
ESMO-ECPC Cancer Survivorship GuideKathi Apostolidis
 
European Cancer Patients Achievements in cancer HTA Advocacy
European Cancer Patients Achievements in cancer HTA AdvocacyEuropean Cancer Patients Achievements in cancer HTA Advocacy
European Cancer Patients Achievements in cancer HTA AdvocacyKathi Apostolidis
 
Για μια εθνική πολιτική για τον καρκίνο
Για μια εθνική πολιτική για τον καρκίνοΓια μια εθνική πολιτική για τον καρκίνο
Για μια εθνική πολιτική για τον καρκίνοKathi Apostolidis
 
Η πρωτοβουλία της Ευρωπαϊκής Επιτροπής για τον καρκίνο του Μαστού
Η πρωτοβουλία της Ευρωπαϊκής Επιτροπής για τον καρκίνο του ΜαστούΗ πρωτοβουλία της Ευρωπαϊκής Επιτροπής για τον καρκίνο του Μαστού
Η πρωτοβουλία της Ευρωπαϊκής Επιτροπής για τον καρκίνο του ΜαστούKathi Apostolidis
 
Η Διαδικτυακή Πύλη Ανοσο-Ογκολογίας της ΕCPC - ECPC Immuno-Oncology Portal
Η Διαδικτυακή Πύλη Ανοσο-Ογκολογίας της ΕCPC - ECPC Immuno-Oncology PortalΗ Διαδικτυακή Πύλη Ανοσο-Ογκολογίας της ΕCPC - ECPC Immuno-Oncology Portal
Η Διαδικτυακή Πύλη Ανοσο-Ογκολογίας της ΕCPC - ECPC Immuno-Oncology PortalKathi Apostolidis
 
Is there patient involvement in HTA? Can patients influence HTA decision making?
Is there patient involvement in HTA? Can patients influence HTA decision making?Is there patient involvement in HTA? Can patients influence HTA decision making?
Is there patient involvement in HTA? Can patients influence HTA decision making?Kathi Apostolidis
 
From disease-centered to patient-centered communication in breast cancer
From disease-centered to patient-centered communication in breast cancerFrom disease-centered to patient-centered communication in breast cancer
From disease-centered to patient-centered communication in breast cancerKathi Apostolidis
 
Tο δικαίωμα στην υγεία ΕΣΔΥ
Tο δικαίωμα στην υγεία ΕΣΔΥTο δικαίωμα στην υγεία ΕΣΔΥ
Tο δικαίωμα στην υγεία ΕΣΔΥKathi Apostolidis
 
The Challenges of Cross-Border Healthcare Law
The Challenges of Cross-Border Healthcare LawThe Challenges of Cross-Border Healthcare Law
The Challenges of Cross-Border Healthcare LawKathi Apostolidis
 
H σχέση & η επικοινωνία με την ιατρική ομάδα από τη πλευρά του ογκολογικού ασ...
H σχέση & η επικοινωνία με την ιατρική ομάδα από τη πλευρά του ογκολογικού ασ...H σχέση & η επικοινωνία με την ιατρική ομάδα από τη πλευρά του ογκολογικού ασ...
H σχέση & η επικοινωνία με την ιατρική ομάδα από τη πλευρά του ογκολογικού ασ...Kathi Apostolidis
 
How Effective is the Public in Influencing HTA Decisions?
How Effective is the Public in Influencing HTA Decisions?How Effective is the Public in Influencing HTA Decisions?
How Effective is the Public in Influencing HTA Decisions?Kathi Apostolidis
 
Reform in healthcare starts with each one of us
Reform in healthcare starts with each one of usReform in healthcare starts with each one of us
Reform in healthcare starts with each one of usKathi Apostolidis
 
ΓΙΑΤΙ ΤΑ ΚΟΙΝΩΝΙΚΑ ΜΕΣΑ ΔΙΑΔΙΚΤΥΟΥ ΕΙΝΑΙ ΑΠΑΡΑΙΤΗΤΑ ΓΙΑ ΚΟΙΝΩΝΙΚΗ ΔΡΑΣΗ
ΓΙΑΤΙ  ΤΑ ΚΟΙΝΩΝΙΚΑ ΜΕΣΑ ΔΙΑΔΙΚΤΥΟΥ ΕΙΝΑΙ ΑΠΑΡΑΙΤΗΤΑ  ΓΙΑ ΚΟΙΝΩΝΙΚΗ ΔΡΑΣΗ ΓΙΑΤΙ  ΤΑ ΚΟΙΝΩΝΙΚΑ ΜΕΣΑ ΔΙΑΔΙΚΤΥΟΥ ΕΙΝΑΙ ΑΠΑΡΑΙΤΗΤΑ  ΓΙΑ ΚΟΙΝΩΝΙΚΗ ΔΡΑΣΗ
ΓΙΑΤΙ ΤΑ ΚΟΙΝΩΝΙΚΑ ΜΕΣΑ ΔΙΑΔΙΚΤΥΟΥ ΕΙΝΑΙ ΑΠΑΡΑΙΤΗΤΑ ΓΙΑ ΚΟΙΝΩΝΙΚΗ ΔΡΑΣΗ Kathi Apostolidis
 
Accessibility and affordability of medicines in Greece
Accessibility and affordability of medicines in GreeceAccessibility and affordability of medicines in Greece
Accessibility and affordability of medicines in GreeceKathi Apostolidis
 
I know and exercise my patient rights when I am ill-Γνωρίζω τα Δικαιώματά μου...
I know and exercise my patient rights when I am ill-Γνωρίζω τα Δικαιώματά μου...I know and exercise my patient rights when I am ill-Γνωρίζω τα Δικαιώματά μου...
I know and exercise my patient rights when I am ill-Γνωρίζω τα Δικαιώματά μου...Kathi Apostolidis
 
H χρησιμότητα του Ε.Α.Ν. για τους ογκολογικούς ασθενείς
H χρησιμότητα του Ε.Α.Ν. για τους ογκολογικούς ασθενείςH χρησιμότητα του Ε.Α.Ν. για τους ογκολογικούς ασθενείς
H χρησιμότητα του Ε.Α.Ν. για τους ογκολογικούς ασθενείςKathi Apostolidis
 

More from Kathi Apostolidis (20)

Why Humanities & Art are important in medical education
Why Humanities & Art are important in medical educationWhy Humanities & Art are important in medical education
Why Humanities & Art are important in medical education
 
ESMO-ECPC Cancer Survivorship Guide
ESMO-ECPC Cancer Survivorship GuideESMO-ECPC Cancer Survivorship Guide
ESMO-ECPC Cancer Survivorship Guide
 
European Cancer Patients Achievements in cancer HTA Advocacy
European Cancer Patients Achievements in cancer HTA AdvocacyEuropean Cancer Patients Achievements in cancer HTA Advocacy
European Cancer Patients Achievements in cancer HTA Advocacy
 
Για μια εθνική πολιτική για τον καρκίνο
Για μια εθνική πολιτική για τον καρκίνοΓια μια εθνική πολιτική για τον καρκίνο
Για μια εθνική πολιτική για τον καρκίνο
 
Barcelona bladder meeting
Barcelona bladder meetingBarcelona bladder meeting
Barcelona bladder meeting
 
Η πρωτοβουλία της Ευρωπαϊκής Επιτροπής για τον καρκίνο του Μαστού
Η πρωτοβουλία της Ευρωπαϊκής Επιτροπής για τον καρκίνο του ΜαστούΗ πρωτοβουλία της Ευρωπαϊκής Επιτροπής για τον καρκίνο του Μαστού
Η πρωτοβουλία της Ευρωπαϊκής Επιτροπής για τον καρκίνο του Μαστού
 
Η Διαδικτυακή Πύλη Ανοσο-Ογκολογίας της ΕCPC - ECPC Immuno-Oncology Portal
Η Διαδικτυακή Πύλη Ανοσο-Ογκολογίας της ΕCPC - ECPC Immuno-Oncology PortalΗ Διαδικτυακή Πύλη Ανοσο-Ογκολογίας της ΕCPC - ECPC Immuno-Oncology Portal
Η Διαδικτυακή Πύλη Ανοσο-Ογκολογίας της ΕCPC - ECPC Immuno-Oncology Portal
 
Is there patient involvement in HTA? Can patients influence HTA decision making?
Is there patient involvement in HTA? Can patients influence HTA decision making?Is there patient involvement in HTA? Can patients influence HTA decision making?
Is there patient involvement in HTA? Can patients influence HTA decision making?
 
From disease-centered to patient-centered communication in breast cancer
From disease-centered to patient-centered communication in breast cancerFrom disease-centered to patient-centered communication in breast cancer
From disease-centered to patient-centered communication in breast cancer
 
Tο δικαίωμα στην υγεία ΕΣΔΥ
Tο δικαίωμα στην υγεία ΕΣΔΥTο δικαίωμα στην υγεία ΕΣΔΥ
Tο δικαίωμα στην υγεία ΕΣΔΥ
 
The Challenges of Cross-Border Healthcare Law
The Challenges of Cross-Border Healthcare LawThe Challenges of Cross-Border Healthcare Law
The Challenges of Cross-Border Healthcare Law
 
H σχέση & η επικοινωνία με την ιατρική ομάδα από τη πλευρά του ογκολογικού ασ...
H σχέση & η επικοινωνία με την ιατρική ομάδα από τη πλευρά του ογκολογικού ασ...H σχέση & η επικοινωνία με την ιατρική ομάδα από τη πλευρά του ογκολογικού ασ...
H σχέση & η επικοινωνία με την ιατρική ομάδα από τη πλευρά του ογκολογικού ασ...
 
How Effective is the Public in Influencing HTA Decisions?
How Effective is the Public in Influencing HTA Decisions?How Effective is the Public in Influencing HTA Decisions?
How Effective is the Public in Influencing HTA Decisions?
 
Reform in healthcare starts with each one of us
Reform in healthcare starts with each one of usReform in healthcare starts with each one of us
Reform in healthcare starts with each one of us
 
Endoflife preso
Endoflife presoEndoflife preso
Endoflife preso
 
ΓΙΑΤΙ ΤΑ ΚΟΙΝΩΝΙΚΑ ΜΕΣΑ ΔΙΑΔΙΚΤΥΟΥ ΕΙΝΑΙ ΑΠΑΡΑΙΤΗΤΑ ΓΙΑ ΚΟΙΝΩΝΙΚΗ ΔΡΑΣΗ
ΓΙΑΤΙ  ΤΑ ΚΟΙΝΩΝΙΚΑ ΜΕΣΑ ΔΙΑΔΙΚΤΥΟΥ ΕΙΝΑΙ ΑΠΑΡΑΙΤΗΤΑ  ΓΙΑ ΚΟΙΝΩΝΙΚΗ ΔΡΑΣΗ ΓΙΑΤΙ  ΤΑ ΚΟΙΝΩΝΙΚΑ ΜΕΣΑ ΔΙΑΔΙΚΤΥΟΥ ΕΙΝΑΙ ΑΠΑΡΑΙΤΗΤΑ  ΓΙΑ ΚΟΙΝΩΝΙΚΗ ΔΡΑΣΗ
ΓΙΑΤΙ ΤΑ ΚΟΙΝΩΝΙΚΑ ΜΕΣΑ ΔΙΑΔΙΚΤΥΟΥ ΕΙΝΑΙ ΑΠΑΡΑΙΤΗΤΑ ΓΙΑ ΚΟΙΝΩΝΙΚΗ ΔΡΑΣΗ
 
Accessibility and affordability of medicines in Greece
Accessibility and affordability of medicines in GreeceAccessibility and affordability of medicines in Greece
Accessibility and affordability of medicines in Greece
 
I know and exercise my patient rights when I am ill-Γνωρίζω τα Δικαιώματά μου...
I know and exercise my patient rights when I am ill-Γνωρίζω τα Δικαιώματά μου...I know and exercise my patient rights when I am ill-Γνωρίζω τα Δικαιώματά μου...
I know and exercise my patient rights when I am ill-Γνωρίζω τα Δικαιώματά μου...
 
Patient Designed Healthcare
Patient Designed HealthcarePatient Designed Healthcare
Patient Designed Healthcare
 
H χρησιμότητα του Ε.Α.Ν. για τους ογκολογικούς ασθενείς
H χρησιμότητα του Ε.Α.Ν. για τους ογκολογικούς ασθενείςH χρησιμότητα του Ε.Α.Ν. για τους ογκολογικούς ασθενείς
H χρησιμότητα του Ε.Α.Ν. για τους ογκολογικούς ασθενείς
 

Recently uploaded

Presentation for Alzheimers Disease.pptx
Presentation for Alzheimers Disease.pptxPresentation for Alzheimers Disease.pptx
Presentation for Alzheimers Disease.pptxravisutar1
 
ANTIGEN- SECTION IMMUNOLOGY DEPARTMENT OF MICROBIOLOGY
ANTIGEN- SECTION IMMUNOLOGY  DEPARTMENT OF MICROBIOLOGYANTIGEN- SECTION IMMUNOLOGY  DEPARTMENT OF MICROBIOLOGY
ANTIGEN- SECTION IMMUNOLOGY DEPARTMENT OF MICROBIOLOGYDrmayuribhise
 
TEENAGE PREGNANCY PREVENTION AND AWARENESS
TEENAGE PREGNANCY PREVENTION AND AWARENESSTEENAGE PREGNANCY PREVENTION AND AWARENESS
TEENAGE PREGNANCY PREVENTION AND AWARENESSPeterJamesVitug
 
Subconjunctival Haemorrhage,causes,treatment..pptx
Subconjunctival Haemorrhage,causes,treatment..pptxSubconjunctival Haemorrhage,causes,treatment..pptx
Subconjunctival Haemorrhage,causes,treatment..pptxvideosfildr
 
Understanding Cholera: Epidemiology, Prevention, and Control.pdf
Understanding Cholera: Epidemiology, Prevention, and Control.pdfUnderstanding Cholera: Epidemiology, Prevention, and Control.pdf
Understanding Cholera: Epidemiology, Prevention, and Control.pdfSasikiranMarri
 
『澳洲文凭』买莫道克大学毕业证书成绩单办理澳洲Murdoch文凭学位证书
『澳洲文凭』买莫道克大学毕业证书成绩单办理澳洲Murdoch文凭学位证书『澳洲文凭』买莫道克大学毕业证书成绩单办理澳洲Murdoch文凭学位证书
『澳洲文凭』买莫道克大学毕业证书成绩单办理澳洲Murdoch文凭学位证书rnrncn29
 
Incentive spirometry powerpoint presentation
Incentive spirometry powerpoint presentationIncentive spirometry powerpoint presentation
Incentive spirometry powerpoint presentationpratiksha ghimire
 
Preventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdf
Preventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdfPreventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdf
Preventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdfAditiAlishetty
 
EHR Market Growth is The Boom Over - Jasper Colin
EHR Market Growth is The Boom Over - Jasper ColinEHR Market Growth is The Boom Over - Jasper Colin
EHR Market Growth is The Boom Over - Jasper ColinJasper Colin
 
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Oleg Kshivets
 
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...Compliatric Where Compliance Happens
 
Learn Tips for Managing Chemobrain or Mental Fogginess
Learn Tips for Managing Chemobrain or Mental FogginessLearn Tips for Managing Chemobrain or Mental Fogginess
Learn Tips for Managing Chemobrain or Mental Fogginessbkling
 
Text Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxText Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxProf. Satyen Bhattacharyya
 
The future of change - strategic translation
The future of change - strategic translationThe future of change - strategic translation
The future of change - strategic translationHelenBevan4
 
FAMILY in sociology for physiotherapists.pptx
FAMILY in sociology for physiotherapists.pptxFAMILY in sociology for physiotherapists.pptx
FAMILY in sociology for physiotherapists.pptxMumux Mirani
 
Low Vision Case (Nisreen mokhanawala).pptx
Low Vision Case (Nisreen mokhanawala).pptxLow Vision Case (Nisreen mokhanawala).pptx
Low Vision Case (Nisreen mokhanawala).pptxShubham
 
Biology class 12 assignment neet level practise chapter wise
Biology class 12 assignment neet level practise chapter wiseBiology class 12 assignment neet level practise chapter wise
Biology class 12 assignment neet level practise chapter wiseNAGKINGRAPELLY
 
Immediate care of newborn, midwifery and obstetrical nursing
Immediate care of newborn, midwifery and obstetrical nursingImmediate care of newborn, midwifery and obstetrical nursing
Immediate care of newborn, midwifery and obstetrical nursingNursing education
 

Recently uploaded (20)

Presentation for Alzheimers Disease.pptx
Presentation for Alzheimers Disease.pptxPresentation for Alzheimers Disease.pptx
Presentation for Alzheimers Disease.pptx
 
ANTIGEN- SECTION IMMUNOLOGY DEPARTMENT OF MICROBIOLOGY
ANTIGEN- SECTION IMMUNOLOGY  DEPARTMENT OF MICROBIOLOGYANTIGEN- SECTION IMMUNOLOGY  DEPARTMENT OF MICROBIOLOGY
ANTIGEN- SECTION IMMUNOLOGY DEPARTMENT OF MICROBIOLOGY
 
TEENAGE PREGNANCY PREVENTION AND AWARENESS
TEENAGE PREGNANCY PREVENTION AND AWARENESSTEENAGE PREGNANCY PREVENTION AND AWARENESS
TEENAGE PREGNANCY PREVENTION AND AWARENESS
 
Subconjunctival Haemorrhage,causes,treatment..pptx
Subconjunctival Haemorrhage,causes,treatment..pptxSubconjunctival Haemorrhage,causes,treatment..pptx
Subconjunctival Haemorrhage,causes,treatment..pptx
 
Understanding Cholera: Epidemiology, Prevention, and Control.pdf
Understanding Cholera: Epidemiology, Prevention, and Control.pdfUnderstanding Cholera: Epidemiology, Prevention, and Control.pdf
Understanding Cholera: Epidemiology, Prevention, and Control.pdf
 
『澳洲文凭』买莫道克大学毕业证书成绩单办理澳洲Murdoch文凭学位证书
『澳洲文凭』买莫道克大学毕业证书成绩单办理澳洲Murdoch文凭学位证书『澳洲文凭』买莫道克大学毕业证书成绩单办理澳洲Murdoch文凭学位证书
『澳洲文凭』买莫道克大学毕业证书成绩单办理澳洲Murdoch文凭学位证书
 
Incentive spirometry powerpoint presentation
Incentive spirometry powerpoint presentationIncentive spirometry powerpoint presentation
Incentive spirometry powerpoint presentation
 
Preventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdf
Preventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdfPreventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdf
Preventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdf
 
EHR Market Growth is The Boom Over - Jasper Colin
EHR Market Growth is The Boom Over - Jasper ColinEHR Market Growth is The Boom Over - Jasper Colin
EHR Market Growth is The Boom Over - Jasper Colin
 
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
 
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...
 
Learn Tips for Managing Chemobrain or Mental Fogginess
Learn Tips for Managing Chemobrain or Mental FogginessLearn Tips for Managing Chemobrain or Mental Fogginess
Learn Tips for Managing Chemobrain or Mental Fogginess
 
Dr Sujit Chatterjee Hiranandani Hospital Kidney.pdf
Dr Sujit Chatterjee Hiranandani Hospital Kidney.pdfDr Sujit Chatterjee Hiranandani Hospital Kidney.pdf
Dr Sujit Chatterjee Hiranandani Hospital Kidney.pdf
 
Text Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxText Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptx
 
The future of change - strategic translation
The future of change - strategic translationThe future of change - strategic translation
The future of change - strategic translation
 
FAMILY in sociology for physiotherapists.pptx
FAMILY in sociology for physiotherapists.pptxFAMILY in sociology for physiotherapists.pptx
FAMILY in sociology for physiotherapists.pptx
 
Low Vision Case (Nisreen mokhanawala).pptx
Low Vision Case (Nisreen mokhanawala).pptxLow Vision Case (Nisreen mokhanawala).pptx
Low Vision Case (Nisreen mokhanawala).pptx
 
Biology class 12 assignment neet level practise chapter wise
Biology class 12 assignment neet level practise chapter wiseBiology class 12 assignment neet level practise chapter wise
Biology class 12 assignment neet level practise chapter wise
 
Kidney Transplant At Hiranandani Hospital
Kidney Transplant At Hiranandani HospitalKidney Transplant At Hiranandani Hospital
Kidney Transplant At Hiranandani Hospital
 
Immediate care of newborn, midwifery and obstetrical nursing
Immediate care of newborn, midwifery and obstetrical nursingImmediate care of newborn, midwifery and obstetrical nursing
Immediate care of newborn, midwifery and obstetrical nursing
 

The Role of Patients & their Challenges in Clinical Trials

  • 1. 1 The 2nd EORTC Cancer Clinical Research Methodology Course for Patient Advocates – Brussels – March 4-5, 2016 The Role of Patients & their Challenges in Clinical Trials How to communicate “trial information & results” to patients Kathi Apostolidis Vice President – European Cancer Patient Coalition President – Hellenic Cancer Federation
  • 2. 2 ECPC: "Nothing about us, without us" • Members: 383 cancer patient organizations in 44 countries • All cancers – common and rare • Run and governed by patients • Promoting timely access to prevention, screening, early diagnosis, treatment & care for all cancer patients • Reducing disparity and inequity across the EU • Encouraging the advance of cancer research & innovation & patient involvement in research • Increasing cancer patients' influence over European health and research policy
  • 3. 3 European Cancer Patient Coalition’s Activities
  • 4. 4 European Commission • Joint Action on Cancer Control – CanCon • Joint Action on Rare Cancers • European Commission’s Expert Group on Cancer Control • European Commission Initiative on Breast Cancer-Quality Assurance Scheme Development Group (ECIBC/QASDG) • Working Group on mHealth guidelines assessment European Medicines Agency • Patients’ and Consumers’ Working Party ECPC: cancer patients’recognised voice
  • 5. 5 What are clinical trials Myths about clinical trials What patients want The role of patients in clinical trials How to communicate trial information How to communicate trial results
  • 6. 6
  • 7. 7 Questions clinical trials can answer  Is a new treatment or combination safe? How much?  Is a new treatment effective?  Is a new treatment better than or same to the currently available treatments?  Will all patients benefit? Or some will benefit less?  Are there biomarkers or other testing to determine which patients will benefit most?
  • 8. 8 Clinical Trial Design Umbrella Trial - lhttp://www.roche.com/media/store/roche_stories/as co-2015-overview/asco-2015-story-2.htmla www.institute-curie.org
  • 9. 9 Myths about Clinical Trials 1st Myth: Clinical Trial as Last Resort 2nd Myth: Patients as Guinea pigs, especially in Phase I 3rd Myth: Placebo 4th Myth: No stopping or Going Back
  • 10. 10 Why patients enter Phase III trials To do social good Trust in his/her doctor Favorable impression of the clinical research associate Lack of pressure to enter the trial Sufficient information for decision making Sufficient time to make decision Favor for clinical trials Expectation to do well Support from family and friends James R. Wright et al. 2004
  • 11. 11 The Role of Patients in Clinical Trials From research subject… …to research partners…
  • 12. 12
  • 13. 13
  • 14. 14 The Advanced Symptom Management System (ASyMS)• Mobile phone-based • Utilises an electronic Patient-Reported Outcomes (ePRO) measure, so ePRO system Sunday, 06 14 Patient completes ePRO symptom questionnaire on mobile phone on a daily basis and whenever he/she feels unwell Data transferred to server and subject to clinical risk algorithm Alerts transmitted to clinician’s handset Evidence- based self- manageme nt advice Amber alert (mild symptoms) Red alert (severe or life- threatening symptoms) E-Library Symptom graphs Clinician logs onto website to review alert and contacts patient Automated message prompts patient to check self- care advice ! !! Real-time Real-time Real-time Real-time
  • 15. 15 Trial results communication to patients • Clinical trials results should be made available to participants • Providing results is the ethical standard • Most patients want to know the results • Women felt it should be their doctor who shares the results • Plan to share the results should be included in the Informed Consent • Guidelines needed for the optimum time to share results • Results should be shared before public disclosure
  • 16. 16 Thank for your attention Nothing about us without us! email : kathi.apostolidis@ecpc.org @cancereu European Cancer Patient Coalition ECPCtv